FRENCH – Publications et travaux en cours

Certains articles sont disponibles, cliquer sur le titre pour obtenir le pdf.

Principales études publiées sous l’égide ou avec la collaboration de FRENCH.

• F Lacaine et FRENCH. European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-10.
• B Suc ; Arch Surg 2004;139:288-94. 
• F Borie ; Ann Surg Oncol 2004;11:512-7
• P Pessaux ; World J Surg 2004;28:92-6.
• J Chipponi ; Am J Surg 2004;187:440-5.
• F Muscari ; Surgery 2005;139:591-8 
• JP Duffas; Am J Surg 2005;189:720–9. ETC
• P Pessaux ; Am J Infect Control 2005;33:292-8. 
• P Pessaux ; Am J Surg 2006;192:165-71. 
• JJ Duron et FRENCH. Adhesive postoperative small bowel obstruction: incidence and risk factors of recurrence after surgical treatment: a multicenter prospective study. Ann Surg 2006;244(5):750-7.
• N Veyrie ; J Am Coll Surg 2007;205:785-93. 
• Millat B ; Fédération de Recherche EN CHirurgie (FRENCH).
  Inguinal hernia repair. A randomized multicentric study comparing laparoscopic and open surgical repair.
  J Chir (Paris). 2007 Mar-Apr;144(2):119-24.
• B Millat et FRENCH. Cure de hernie chez l’homme. Etude multicentrique randomisée comparant coelioscopie versus voie ouverte. J Chir 2007;144(2):119-24.
• F Muscari ; J Am Coll Surg 2008;207:888-95. 
• JJ Duron. Prevalence and risk factors of mortality and morbidity after operation for adhesive postoperative small bowel obstruction. Am J Surg 2008;195(6):726-34.
• B Suc ; Ann Surg 2009;237(1):57–65. 
• P Tran Ba Loc ; Br J Surg 2010;97:396-403.
• C. Mariette et FRENCH et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection. JAMA 2010; 304(10): 1073-81.
• P Pessaux ; Ann Surg 2011;253:879-85. 
• JJ Duron ; Ann Surg 2011;254:375-82. 
• G. Piessen ; Arch Surg 2011;146:1149-55. 
• M Messager ; Ann Surg 2011;254:684-93. 
• P Pessaux ;  Ann Surg. 2011 
• Pessaux P, et al Fédération de Recherche en Chirurgie (French).
  External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial.
  Ann Surg. 2011 May;253(5):879-85
• Piessen G, et al FRENCH (Fédération de Recherche en CHirurgie).
  Prevalence of and risk factors for morbidity after elective left colectomy: cancer vs noncomplicated diverticular disease.
  Arch Surg. 2011 Oct;146(10):1149-55.
• F Lacaine ;  JAMA 2012 
• C Mariette ;  JAMA 2013 C Mariette ;  Surgery 2013 
• Bekkar S, et al. French Eso-Gastric Tumors Working Group – Fédération de Recherche en Chirurgie. 
  The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma. 
  Ann Thorac Surg. 2014 Jan;97(1):303-10.
• JAMA. 2014 Jul;312(2):145-54. doi: 10.1001/jama.2014.7586.
  Effect of postoperative antibiotic administration on postoperative infection following cholecystectomy for acute calculous cholecystitis: a randomized clinical trial.
  Regimbeau JM, Fuks D, Pautrat K, Mauvais F, Haccart V, Msika S, Mathonnet M, Scotté M, Paquet JC, Vons C, Sielezneff I, Millat B, Chiche L, Dupont H, Duhaut P, Cossé C, Diouf M, Pocard M; FRENCH Study Group.
• Bouvier A. et al. Federation de Recherche en Chirurgie (FRENCH).
  Abdominal binders after laparotomy: review of the literature and French survey of policies.
  Hernia. 2014 Aug;18(4):501-6.
• Mariette et al.
  Self-Expanding Covered Metallic Stent as a Bridge to Surgery in Esophageal Cancer: Impact on Oncologic Outcomes
  J Am Coll Surg 2015;220:287e296
• William B. Robb, et al.
  High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes?
  Ann Surg Oncol (2015) 22:3632–3639, DOI 10.1245/s10434-015-4423-5
• Sheraz Markar, et al.
  Pattern of Postoperative Mortality After Esophageal Cancer Resection According to Center Volume: Results from a Large European Multicenter Study
  Ann Surg Oncol (2015) 22:2615–2623 DOI 10.1245/s10434-014-4310-5
• Pessaux P, Marzano E; FRENCH (Fédération de Recherche en Chirurgie).
  Reply to letter: « pancreatic fistula after pancreaticoduodenectomy ».
  Ann Surg. 2015 Feb;261(2):e35.
• William B. Robb, et al.
  Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer Post hoc Analysis of a Randomized Controlled Trial
  Annals of Surgery : Volume 261, Number 5, May 2015
• Guillaume Luc, MD et al.
  Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study
  Ann Surg Oncol: May 2015, DOI 10.1245/s10434-015-4619-8
• Sheraz Markar, et al.
  Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
  J Clin Oncol July 2015 , vol 33: 1-8. The latest version is at http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.9092
• W. B. Robb1, et al.
  Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone
  BJS September 2015 DOI: 10.1002/bjs.9959
• Sa Cunha A, et al. Federation de Recherche en Chirurgie (FRENCH).
  Stump closure reinforcement with absorbable fibrin collagen sealant sponge (TachoSil) does not prevent pancreatic fistula after distal pancreatectomy: the FIABLE multicenter controlled randomized study.
  Am J Surg. 2015 Oct;210(4):739-48.
• Lermite et al.
  Postoperative biological and clinical outcomes following uncomplicated pancreaticoduodenectomy.
  Korean J Hepatobiliary Pancreat Surg. 2016 Feb;20(1):23-31
• Schwarz et al.
  Bleeding Recurrence and Mortality Following Interventional Management of Spontaneous HCC Rupture: Results of a Multicenter European Study.
  World J Surg. 2018 Jan;42(1):225-232.
• Karoui et al.
  Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial–the PRODIGE 22–ECKINOXE trial.
  BMC Cancer. 2015 Jul 10;15:511.
• Cotte et al.
  GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study.
  BMC Cancer. 2015; 15: 47

COLLABORATION FRENCH et FREGAT :

• Sheraz Markar, et al. The Impact of Severe Anastomotic Leak on Long-term Survival and Cancer Recurrence After Surgical Resection for Esophageal Malignancy
• Gronnier et al. Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection. Results of a European Multicenter study. Ann Surg 2014 Nov;260(5):764-70
• Markar et al. The Impact of Severe Anastomotic Leak on Long-term Survival and Cancer Recurrence After Surgical Resection for Esophageal Malignancy. Ann Surg. 2015 Dec;262(6):972-80.
• Messager et al. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011 Nov;254(5):684-93; discussion 693.
• Honoré et al. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study. Eur J Surg Oncol. 2013 Mar;39(3):235-41.
• Gronnier et al. Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma? Surgery. 2013 Nov;154(5):1093-9.
• Mariette et al. Palliative resection for advanced gastric and junctional adenocarcinoma: which patients will benefit from surgery? Ann Surg Oncol. 2013 Apr;20(4):1240-9. 
• Robb et al. Predictive factors of postoperative mortality after junctional and gastric adenocarcinoma resection JAMA Surg. 2013 Jul;148(7):624-31
• Robb et al. Esophageal gastrointestinal stromal tumor: is tumoral enucleation a viable therapeutic option? Ann Surg. 2015 Jan;261(1):117-24.
• Bekkar et al. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma. Ann Thorac Surg. 2014 Jan;97(1):303-10.
• Signet ring cell adenocarcinomas: Different clinicalepathological characteristics of oesophageal and gastric locations.
• G.Passot, et al, Fédération de Recherche en Chirurgie (FRENCH). Definition of Giant Ventral Hernias: Development of Standardization through a Practice Survey Original Research Article. Int J Surg. 2016 Apr;28:136-40.
• Markar et al. Pattern of postoperative mortality after esophageal cancer resection according to center volume: results from a large European multi-center study. Ann Surg Oncol 2015 Aug;22(8):2615-23.
• Luc et al. Predictive factors of recurrence in patients with pathological complete response after esophagectomy following neoadjuvant chemoradiotherapy for esophageal cancer: A multicenter study. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1357-64.
• Mariette et al. Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncological outcomes. J Am Coll Surg 2015 Mar;220(3):287-96
• Voron et al. Are signet-ring cell carcinoma a specific entity among gastric cancers? Gastric Cancer. 2016 Oct;19(4):1027-40.
• Cohen et al. Salvage Surgery for Esophageal Cancer: How to Improve Outcomes? Ann Surg Oncol. 2018 Feb 7
• Renaud et al. Ann Pathol. 2017 Dec;37(6):457-466. 
• Markar et al. Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy. Ann Surg Oncol. 2017 Dec;24(13):3911-3920.
• Mantziari et al. Survival Benefit of Neoadjuvant Treatment in Clinical T3N0M0 Esophageal Cancer: Results From a Retrospective Multicenter European Study. Ann Surg. 2017 Nov;266(5):805-813.
• Markar et al. Surgically treated oesophageal cancer developed in a radiated field: Impact on peri-operative and long-term outcomes. Eur J Cancer. 2017 Apr;75:179-189.
• Mantziari S, Gronnier C, Pasquer A, Gagnière J, Théreaux J, Demartines N, Schäfer M, Mariette C; FREGAT Working Group–FRENCH–AFC. Incidence and Risk Factors Related to Symptomatic Venous Thromboembolic Events After Esophagectomy for Cancer. Ann Thorac Surg. 2016 Sep;102(3):979-984.
• Bekkar et al. Multicentre study of neoadjuvant chemotherapy for stage I and II oesophageal cancer. Br J Surg. 2016 ;103(7):855-62
• Markar et al. Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study. Eur J Cancer. 2016 Mar;56:59-68
• Messageret al. Laparoscopic Gastric Mobilization Reduces Postoperative Mortality After Esophageal Cancer Surgery: A French Nationwide Study. Ann Surg. 2015 Nov;262(5):817-22; discussion 822-3.
• Markar et al. Significance of Microscopically Incomplete Resection Margin After Esophagectomy for Esophageal Cancer. Ann Surg. 2016 Apr;263(4):712-8.
• Robb et al. High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes? Ann Surg Oncol. 2015 Oct;22(11):3632-9.